NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer's Disease

被引：6
|
作者：
Painuli, Sakshi [1 ,2 ]
Semwal, Prabhakar [2 ]
Zam, Wissam [3 ]
Taheri, Yasaman [4 ]
Ezzat, Shahira M. [5 ,6 ]
Zuo, Peijun [7 ]
Li, Liping [7 ]
Kumar, Dileep [8 ]
Sharifi-Rad, Javad [9 ,13 ]
Cruz-Martins, Natalia [10 ,11 ,12 ,14 ]
机构：
[1] Himalayan Environm Studies & Conservat Org HESCO, Dehra Dun 248006, India
[2] Graphic Era Deemed be Univ, Dept Life Sci, Dehra Dun 248002, India
[3] Tartous Univ, Fac Pharm, Dept Analyt & Food Chem, Tartous, Syria
[4] Shahid Beheshti Univ Med Sci, Phytochem Res Ctr, Tehran, Iran
[5] Cairo Univ, Fac Pharm, Dept Pharmacognosy, Cairo 11562, Egypt
[6] October Univ Modern Sci & Arts MSA, Fac Pharm, Dept Pharmacognosy, Giza 12451, Egypt
[7] Shantou Univ, Sch Publ Hlth, Shantou, Guangdong, Peoples R China
[8] Bharati Vidyapeeth Deemed be Univ, Poona Coll Pharm, Pune 411038, Maharashtra, India
[9] Univ Azuay, Fac Med, Cuenca, Ecuador
[10] Univ Porto, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal
[11] Univ Porto, Inst Res & Innovat Hlth i3S, P-4200135 Porto, Portugal
[12] Inst Res & Adv Training Hlth Sci & Technol CESPU, Rua Cent Gandra 1317, P-4585116 Gandra, Portugal
[13] Univ Azuay, Fac Med, Cuenca, Ecuador
[14] Univ Porto, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal
来源：
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING | 2023年 / 26卷 / 12期
关键词：
Alzheimer's disease; neurodegeneration; N-methyl D-aspartate (NMDA) receptors; precision medicine; NMDA; dimensia; METHYL-D-ASPARTATE; AMYLOID PRECURSOR PROTEIN; LONG-TERM-POTENTIATION; A-BETA ACCUMULATION; APOLIPOPROTEIN-E; SYNAPTIC PLASTICITY; MODERATELY SEVERE; TYROSINE PHOSPHORYLATION; RECEPTOR ANTAGONIST; GLUTAMATE TOXICITY;
D O I：
10.2174/1386207325666220428112541
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Alzheimer's disease (AD) is an increasingly common neurodegenerative disease that attracts the attention of researchers and medical community in order to develop new, safe and more effective drugs. Currently available drugs could only slow the AD progression and relieve the symptoms, in addition to being linked to moderate-to-severe side effects. N-methyl D-aspartate (NMDA) receptors antagonists were reported to have the ability to block the glutamate-mediated excitotoxic activity being good therapeutic targets for several neurodegenerative diseases, including AD. Based on data obtained so far, this review provides an overview over the use of NMDA antagonists for AD treatment, starting with a key emphasis on present features and future aspects regarding the use of NMDA antagonists for AD, and lastly a key focus is also given on its use in precision medicine.
引用
收藏
页码：2099 / 2112
页数：14
相关论文
共 50 条
  • [41] GSK-3 inhibitors and their potential in the treatment of Alzheimer's disease
    Kypta, RM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (10) : 1315 - 1331
  • [42] Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease
    Xi, Meiyang
    Sun, Tianyu
    Chai, Shejie
    Xie, Mengjiao
    Chen, Siqi
    Deng, Liping
    Du, Kui
    Shen, Runpu
    Sun, Haopeng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 232
  • [43] Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease
    Konrath, Eduardo Luis
    Passos, Carolina dos Santos
    Klein-Junior, Luiz Carlos
    Henriques, Amelia T.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (12) : 1701 - 1725
  • [44] Honey as the Potential Natural Source of Cholinesterase Inhibitors in Alzheimer’s Disease
    Ewa Baranowska-Wójcik
    Dominik Szwajgier
    Anna Winiarska-Mieczan
    Plant Foods for Human Nutrition, 2020, 75 : 30 - 32
  • [45] Genetic Phenotypes of Alzheimer's Disease: Mechanisms and Potential Therapy
    Quan, Meina
    Cao, Shuman
    Wang, Qi
    Wang, Shiyuan
    Jia, Jianping
    PHENOMICS, 2023, 3 (04): : 333 - 349
  • [46] Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease
    Eddin, Ahmed Noor
    Hamsho, Khaled
    Adi, Ghaith
    Al-Rimawi, Mohammed
    Alfuwais, Mohammed
    Rab, Saleha Abdul
    Alkattan, Khaled
    Yaqinuddin, Ahmed
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [47] Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease
    Wang, Shudan
    Yao, Hongyang
    Xu, Yihua
    Hao, Rui
    Zhang, Wen
    Liu, Hang
    Huang, Ying
    Guo, Wei
    Lu, Bai
    THERANOSTICS, 2020, 10 (15): : 6854 - 6874
  • [48] Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease
    Manna, Ida
    De Benedittis, Selene
    Quattrone, Andrea
    Maisano, Domenico
    Iaccino, Enrico
    Quattrone, Aldo
    PHARMACEUTICALS, 2020, 13 (09) : 1 - 16
  • [49] Cellular Reprogramming and Its Potential Application in Alzheimer's Disease
    Zhou, Chao
    Ni, Wanyan
    Zhu, Taiyang
    Dong, Shuyu
    Sun, Ping
    Hua, Fang
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [50] The Potential Role of Rho GTPases in Alzheimer's Disease Pathogenesis
    Bolognin, Silvia
    Lorenzetto, Erika
    Diana, Giovanni
    Buffelli, Mario
    MOLECULAR NEUROBIOLOGY, 2014, 50 (02) : 406 - 422
12345